Advertisement
Screener

Establishment Labs Holdings Inc. (ESTA) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

Establishment Labs Holdings Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

Establishment Labs Holdings Inc. (ESTA) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 1.42 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-07

  • Establishment Labs Holdings Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 1.83M shares, a 9.94% decline year-over-year.
  • Establishment Labs Holdings Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 2.03M shares, a 10.84% increase year-over-year.
  • Establishment Labs Holdings Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 1.83M shares, a 0.44% decline year-over-year.
  • Establishment Labs Holdings Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 1.84M shares, a 2.37% increase year-over-year.
  • Establishment Labs Holdings Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 1.76M shares, a 2.95% increase from fiscal 2024.
  • Establishment Labs Holdings Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 1.71M shares, a 1.55% increase from fiscal 2023.
  • Establishment Labs Holdings Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 1.68M shares, a 5.83% decline from fiscal 2022.
  • Establishment Labs Holdings Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 1.79M shares, a 3.76% decline from fiscal 2021.
Period endAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed
2026-06-301.42M shares
10-Q · filed 2026-08-07
2026-03-311.83M shares
10-Q · filed 2026-05-08
2025-12-311.76M shares
10-K · filed 2026-02-27
2025-09-301.99M shares
10-Q · filed 2025-11-07
2025-06-302.02M shares
10-Q · filed 2026-08-07
2025-03-312.03M shares
10-Q · filed 2026-05-08
2024-12-311.71M shares
10-K · filed 2026-02-27
2024-09-301.74M shares
10-Q · filed 2025-11-07
2024-06-301.72M shares
10-Q · filed 2025-08-07
2024-03-311.83M shares
10-Q · filed 2025-05-09
2023-12-311.68M shares
10-K · filed 2026-02-27
2023-09-301.79M shares
10-Q · filed 2024-11-12
2023-06-301.80M shares
10-Q · filed 2024-08-07
2023-03-311.84M shares
10-Q · filed 2024-05-09
2022-12-311.79M shares
10-K · filed 2025-02-28
2022-09-301.77M shares
10-Q · filed 2023-11-08
2022-06-302.02M shares
10-Q · filed 2023-08-09
2022-03-311.80M shares
10-Q · filed 2023-05-10
2021-12-311.86M shares
10-K · filed 2024-03-04
1.88M shares
10-K · filed 2022-03-01
2021-09-301.90M shares
10-Q · filed 2022-11-09
1.90M shares
10-Q · filed 2021-11-09
2021-06-302.10M shares
10-Q · filed 2022-08-09
2021-03-311.95M shares
10-Q · filed 2022-05-10
2020-12-311.81M shares
10-K · filed 2023-03-01
2020-09-301.84M shares
10-Q · filed 2021-11-09
2020-06-302.00M shares
10-Q · filed 2021-07-30
2020-03-311.75M shares
10-Q · filed 2021-05-06
2019-12-311.82M shares
10-K · filed 2022-03-01
2019-09-301.88M shares
10-Q · filed 2020-11-09
2019-06-302.07M shares
10-Q · filed 2020-08-07
2019-03-311.83M shares
10-Q · filed 2020-05-08
2018-12-311.91M shares
10-K · filed 2020-03-16
2018-09-301.97M shares
10-Q · filed 2019-11-12
2018-06-301.57M shares
10-Q · filed 2019-08-13
2018-03-311.52M shares
10-Q · filed 2019-05-15
2017-12-311.59M shares
10-K · filed 2019-03-20
2017-09-301.55M shares
10-Q · filed 2018-11-13
2017-06-307.41M shares
10-Q · filed 2018-09-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Enovis CORP (ENOV)United States$1.053B-1.18
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81
Inogen Inc (INGN)United States$0.139B-7.00
Conexeu Sciences Inc. (CNXU)United States$0.111B
NutriBand Inc. (NTRB)United States$0.109B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
Safe Pro Group Inc. (SPAI)United States$0.090B
MYOMO, INC. (MYO)United States$0.065B-2.85